Home › Research › Brain scans and imaging
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old
Barkhof F, Polvikoski TM, van Straaten EC, Kalaria RN, Sulkava R, Aronen HJ, Niinistö L, Rastas S et al.. Neurology, 2007-10-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Background Medial temporal lobe atrophy (MTA) is a sensitive radiologic marker for Alzheimer disease (AD) and associated with cognitive impairment. The value of MTA in the oldest old (>85 years old) is largely unknown. Methods A total of 132 formalin-fixed brains from the Vantaa 85+ community-based study were subjected to postmortem MRI. Visual ratings of MTA were determined in a blinded fashion and compared with neuropathologic findings and clinical assessment (dementia according to Diagnostic and Statistical Manual of Mental Disorders-III-R). Results A strong relationship was found between MTA scores and Alzheimer pathology (p 2 correctly excluded subjects with no or borderline Alzheimer-type pathology (45/48), but was not very sensitive for AD (modified National Institute on Aging-Reagan Institute criteria). MTA scores >2 were also found in subjects with other primary neurodegenerative hippocampal pathology including hippocampal sclerosis, Lewy-related pathology, and argyrophilic grain disease, either alone or in combination with Alzheimer-type pathology. High MTA scores were associated with clinical dementia-in this subgroup, sensitivity was 63% and specificity 69% for AD. Conclusion Medial temporal lobe atrophy (MTA) on postmortem MRI is sensitive to primary degenerative hippocampal pathology in the very old, but not specific for Alzheimer-type pathology. MTA scores of 2 or less are not frequently associated with dementia.
What this study adds
Evidence grade: Low
The record lists 132 participants. In 132 brains from people over 85 (Vantaa 85+ study), scanned by MRI after death, shrinkage of the brain's memory region (medial temporal lobe atrophy) tracked Alzheimer pathology. It also appeared with hippocampal sclerosis, Lewy-related pathology and argyrophilic grain disease, so in the very old it signals hippocampal damage, not Alzheimer's specifically.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Barkhof, F., Polvikoski, T. M., van Straaten, E. C., Kalaria, R. N., Sulkava, R., Aronen, H. J., et al. (2007). The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology. https://doi.org/10.1212/01.wnl.0000277459.83543.99
Vancouver
Barkhof F, Polvikoski TM, van Straaten EC, Kalaria RN, Sulkava R, Aronen HJ, et al. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology. 2007. doi:10.1212/01.wnl.0000277459.83543.99. PMID: 17923614.
BibTeX
@article{barkhof2007-17923614,
author = {Barkhof, F. and Polvikoski, T. M. and van Straaten, E. C. and Kalaria, R. N. and Sulkava, R. and Aronen, H. J. and Niinistö, L. and Rastas, S. and others},
title = {{The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old}},
journal = {Neurology},
year = {2007},
doi = {10.1212/01.wnl.0000277459.83543.99},
pmid = {17923614},
url = {https://doi.org/10.1212/01.wnl.0000277459.83543.99}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Background Medial temporal lobe atrophy (MTA) is a sensitive radiologic marker for Alzheimer disease (AD) and associated with cognitive impairment.
- Visual ratings of MTA were determined in a blinded fashion and compared with neuropathologic findings and clinical assessment (dementia according to Diagnostic and Statistical Manual of Mental Disorders-III-R).
- Results A strong relationship was found between MTA scores and Alzheimer pathology (p 2 correctly excluded subjects with no or borderline Alzheimer-type pathology (45/48), but was not very sensitive for AD (modified National Institute on Aging-Reagan Institute criteria).
- High MTA scores were associated with clinical dementia-in this subgroup, sensitivity was 63% and specificity 69% for AD.
- MTA scores of 2 or less are not frequently associated with dementia.
Why it matters
In 132 brains from people over 85 (Vantaa 85+ study), scanned by MRI after death, shrinkage of the brain's memory region (medial temporal lobe atrophy) tracked Alzheimer pathology. It also appeared with hippocampal sclerosis, Lewy-related pathology and argyrophilic grain disease, so in the very old it signals hippocampal damage, not Alzheimer's specifically. Low atrophy scores (2 or less) were "not frequently associated with dementia". The study tested no treatment.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Participants132
- Evidence strengthLow
How this study scored 53/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2007 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 132 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 204 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.7 citations a year over 21 year(s) since 2007 |
| Impact for its field and year | 3 / 6 | Cited 4.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 19 other studies in this library |
| Still being cited | 2 / 4 | Cited 27 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Timo Erkinjuntti: h-index 82 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Helsinki: institution h-index 1,201 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 17923614) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1212/01.wnl.0000277459.83543.99
- PubMed: 17923614
- Original source →
- Free full text: Newcastle University ePrints (Newcastle Univesity) →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
19 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Brain scans and imaging from nearby years
Also tagged “machine”
834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.